Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blue-blocking Glasses for Treating Evening Activation and Sleep Disorders in Child and Adolescent Psychiatry - a Pilot Trans-diagnostic Randomized Controlled Trial.

NCT07433491 is registered in ClinicalTrials.gov with Helse Fonna as lead sponsor.

NCT NCT07433491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07433491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blue-blocking Glasses for Treating Evening Activation and Sleep Disorders in Child and Adolescent Psychiatry - a Pilot Trans-diagnostic Randomized Controlled Trial.
Lead sponsor
Helse Fonna
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2026
Completion date
June 1, 2027
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

child and adolescent psychiatry, delayed sleep phase disorder, hyperarousal, insomnia, transdiagnostic psychopathology